JG
Jefferies Group’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-11,214
| Closed | -$507K | – | 1146 |
|
|
2022
Q2 | $507K | Buy |
11,214
+10,457
| +1,381% | +$473K | ﹤0.01% | 587 |
|
|
2022
Q1 | $38.5K | Buy |
+757
| New | +$38.5K | ﹤0.01% | 925 |
|
|
2021
Q4 | – | Sell |
-165,038
| Closed | -$5.44M | – | 1043 |
|
|
2021
Q3 | $5.44M | Sell |
165,038
-344,091
| -68% | -$11.3M | 0.04% | 199 |
|
|
2021
Q2 | $32.2M | Buy |
509,129
+492,996
| +3,056% | +$31.2M | 0.2% | 24 |
|
|
2021
Q1 | $692K | Buy |
+16,133
| New | +$692K | 0.01% | 637 |
|
|
2020
Q3 | – | Sell |
-70,976
| Closed | -$2.32K | – | 856 |
|
|
2020
Q2 | $2.32K | Buy |
70,976
+58,515
| +470% | +$1.91K | 0.03% | 273 |
|
|
2020
Q1 | $334K | Buy |
+12,461
| New | +$334K | ﹤0.01% | 732 |
|
|
2019
Q4 | – | Sell |
-13,429
| Closed | -$324K | – | 1594 |
|
|
2019
Q3 | $324K | Buy |
+13,429
| New | +$324K | ﹤0.01% | 1264 |
|